Fig. 1From: Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapyCumulative incidences of HBV relapse after cessation of antiviral prophylactic entecavir and tenofovir alafenamide (TAF) therapy for all patients. A Virological relapse B clinical relapseBack to article page